These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26863385)

  • 1. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Iorio R; Ranucci G
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26863385
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Sintusek P; Dhawan A
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26690865
    [No Abstract]   [Full Text] [Related]  

  • 3. Wilson disease.
    Houwen RH; van Hattum J; Hoogenraad TU
    Neth J Med; 1993 Aug; 43(1-2):26-37. PubMed ID: 8232692
    [No Abstract]   [Full Text] [Related]  

  • 4. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
    Dastych M; Procházková D; Pokorný A; Zdrazil L
    Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 'free' copper in Wilson disease.
    Walshe JM
    QJM; 2012 May; 105(5):419-23. PubMed ID: 22139498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma non-ceruloplasmin copper in hepatocerebral dystrophy (criterion for the diagnosis and evaluation of cuprogogue therapy)].
    Botvinnik VS; Lekar' PG; Makarova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):334-7. PubMed ID: 7257674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease.
    Geetha A; Jeyachristy SA; Selvamathy SM; Ilavarasi S; Surendran R
    Clin Chim Acta; 2007 Aug; 383(1-2):165-7. PubMed ID: 17573059
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc].
    Dastych M
    Vnitr Lek; 1999 Apr; 45(4):217-9. PubMed ID: 11045182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 10. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
    Squitti R; Ghidoni R; Simonelli I; Ivanova ID; Colabufo NA; Zuin M; Benussi L; Binetti G; Cassetta E; Rongioletti M; Siotto M
    J Trace Elem Med Biol; 2018 Jan; 45():181-188. PubMed ID: 29173477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 12. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 15. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
    Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
    Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
    Rosenberger K
    Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the serum copper-oxidase activity in 8 families affected by Struempell-Wilson disease (hepatolentricular degeneration)].
    GIAGHEDDU M; CHESS-PERLE E
    Sist Nerv; 1961; 13():237-52. PubMed ID: 13898276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.